The 18 important medicines that Australians are missing out on
Summary
Pharmaceutical companies warn Australia’s complex approvals process is turning off drug companies, as the Trump administration stokes global pricing pressures. Just a quarter of new medicines launched globally in the last decade have been subsidised in Australia, putting life-changing treatments out-of-reach for patients, in a situation that pharmaceutical companies warn is becoming untenable.